By Connor Hart
Ginkgo Bioworks promoted its chief accounting officer, Steven Coen, to its top finance role.
Coen will succeed Mark Dmytruk, who intends to resign from his role at the biotech company on May 30 to accept a position at another organization, it said Wednesday.
Coen, who is 59 years old, has more than 30 years of public accounting and corporate finance leadership experience, according to Ginkgo.
Prior to joining the company in 2023, he served as corporate controller for Charles River Laboratories. Coen previously held accounting and finance roles in the technology and medical-device industries, and spent more than 17 years in the audit practice at Deloitte & Touche.
As CFO, Coen will receive an annual base salary of $460,000, according to a filing with the Securities and Exchange Commission. He will additionally receive a performance-based restricted stock units award for nearly 68,000 shares of the company's Class A common stock.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
May 21, 2025 17:08 ET (21:08 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.